Sean David to Adult
This is a "connection" page, showing publications Sean David has written about Adult.
Connection Strength
0.672
-
Effects of Social Determinants and Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions. Ann Fam Med. 2024 Nov 01; 21(Suppl 3).
Score: 0.061
-
Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting. J Prim Care Community Health. 2020 Jan-Dec; 11:2150132720981297.
Score: 0.043
-
Extended treatment for cigarette smoking cessation: a randomized control trial. Addiction. 2017 Aug; 112(8):1451-1459.
Score: 0.036
-
Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open. 2016 06 29; 6(6):e010960.
Score: 0.034
-
Systematic review and meta-analysis of opioid antagonists for smoking cessation. BMJ Open. 2014 Mar 14; 4(3):e004393.
Score: 0.029
-
Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry. 2012 May 22; 2:e119.
Score: 0.026
-
Effect of Sickle Cell Trait and APOL1 Genotype on the Association of Soluble uPAR with Kidney Function Measures in Black Americans. Clin J Am Soc Nephrol. 2021 Feb 08; 16(2):287-289.
Score: 0.023
-
Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. Drug Alcohol Depend. 2008 Nov 01; 98(1-2):77-85.
Score: 0.020
-
Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob Res. 2007 12; 9(12):1251-7.
Score: 0.019
-
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res. 2007 Aug; 9(8):821-33.
Score: 0.018
-
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. Pharmacogenomics J. 2008 Apr; 8(2):122-8.
Score: 0.018
-
The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. Nicotine Tob Res. 2007 Feb; 9(2):225-31.
Score: 0.018
-
Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry. 2005 Sep 15; 58(6):488-94.
Score: 0.016
-
A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci. 2005 Mar 09; 25(10):2586-90.
Score: 0.016
-
Declination of Treatment, Racial and Ethnic Disparity, and Overall Survival in US Patients With Breast Cancer. JAMA Netw Open. 2024 05 01; 7(5):e249449.
Score: 0.015
-
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res. 2003 Dec; 5(6):935-42.
Score: 0.014
-
Do medications increase the efficacy of digital interventions for smoking cessation? Secondary results from the iCanQuit randomized trial. Addiction. 2024 04; 119(4):664-676.
Score: 0.014
-
Comment on "The public health implications of smoking-induced decreased serum and red blood cell folate levels". Nicotine Tob Res. 2003 Jun; 5(3):397-9.
Score: 0.014
-
Cross-sectional online survey of clinicians' knowledge, attitudes and challenges to screening and counselling adolescents and young adults for substance use. BMJ Open. 2022 11 22; 12(11):e059019.
Score: 0.013
-
No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics. 2002 Apr; 12(3):265-8.
Score: 0.013
-
Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease. Circulation. 2022 Feb; 145(5):357-370.
Score: 0.012
-
Should we recommend nicotine replacement therapy? Am Fam Physician. 2001 Jun 01; 63(11):2245-7.
Score: 0.012
-
Target specific serologic analysis of COVID-19 convalescent plasma. PLoS One. 2021; 16(4):e0249938.
Score: 0.012
-
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium. Genome Med. 2021 Apr 21; 13(1):66.
Score: 0.012
-
Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2020 10; 586(7831):763-768.
Score: 0.011
-
De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population. Proc Natl Acad Sci U S A. 2020 02 04; 117(5):2560-2569.
Score: 0.011
-
Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children With Asthma. Chest. 2019 12; 156(6):1068-1079.
Score: 0.011
-
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database Syst Rev. 2017 09 08; 9:CD011823.
Score: 0.009
-
Medical school curriculum characteristics associated with intentions and frequency of tobacco dependence treatment among 3rd year U.S. medical students. Prev Med. 2015 Mar; 72:56-63.
Score: 0.008
-
Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers. Nicotine Tob Res. 2015 Jul; 17(7):855-61.
Score: 0.008
-
Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype. Nicotine Tob Res. 2014 Jul; 16(7):939-47.
Score: 0.007
-
Clinical interpretation and implications of whole-genome sequencing. JAMA. 2014 Mar 12; 311(10):1035-45.
Score: 0.007
-
Tobacco dependence treatment teaching by medical school clerkship preceptors: survey responses from more than 1,000 US medical students. Prev Med. 2013 Aug; 57(2):81-6.
Score: 0.007
-
Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study. Nicotine Tob Res. 2013 Feb; 15(2):518-26.
Score: 0.007
-
Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol. 2012 May; 36(4):340-51.
Score: 0.006
-
The neuroeconomics of nicotine dependence: a preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers. Psychiatry Res. 2012 Apr 30; 202(1):20-9.
Score: 0.006
-
Relationship between amounts of daily cigarette consumption and abdominal obesity moderated by CYP2A6 genotypes in Chinese male current smokers. Ann Behav Med. 2012 Apr; 43(2):253-61.
Score: 0.006
-
Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers. J Hum Hypertens. 2013 Jan; 27(1):24-30.
Score: 0.006
-
Chronic psychosocial stressors and salivary biomarkers in emerging adults. Psychoneuroendocrinology. 2012 Aug; 37(8):1158-70.
Score: 0.006
-
Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways. Eur J Endocrinol. 2011 Dec; 165(6):961-7.
Score: 0.006
-
Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):7-13.
Score: 0.006
-
Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction. 2011 May; 106(5):985-94.
Score: 0.006
-
Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. Pharmacogenomics J. 2012 Feb; 12(1):86-92.
Score: 0.006
-
Effects of nicotine withdrawal on verbal working memory and associated brain response. Psychiatry Res. 2010 Jul 30; 183(1):69-74.
Score: 0.006
-
Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry. 2008 Jun; 65(6):683-93.
Score: 0.005
-
Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: a diffusion tensor imaging study. Nicotine Tob Res. 2008 Jan; 10(1):137-47.
Score: 0.005
-
Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev. 2007 Jun; 16(6):1065-9.
Score: 0.005
-
Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. Nicotine Tob Res. 2004 Oct; 6(5):769-76.
Score: 0.004